Literature DB >> 9234802

Borrelia burgdorferi-pulsed dendritic cells induce a protective immune response against tick-transmitted spirochetes.

M L Mbow1, N Zeidner, N Panella, R G Titus, J Piesman.   

Abstract

Borrelia burgdorferi-pulsed dendritic cells and epidermal cells were able to initiate the production of anti-outer surface protein A (OspA) antibody in vitro with normal T and B cells from either BALB/c or C3H/HeJ mice. Inhibition of anti-B. burgdorferi antibody production was observed after 3 days, but not after 2 days, of exposure of the antigen-presenting cells to tumor necrosis factor alpha +/- granulocyte-macrophage colony-stimulating factor. Furthermore, splenic dendritic cells pulsed in vitro with live B. burgdorferi spirochetes and then adoptively transferred into naive syngeneic mice mediated a protective immune response against tick-transmitted spirochetes. This protection appeared not to be due to killing of spirochetes in the feeding ticks, since ticks fed to repletion on B. burgdorferi-pulsed dendritic cell-sensitized mice still harbored live spirochetes. Western blot analysis of the sera collected from dendritic cell-sensitized mice demonstrated that the mice responded to a limited set of B. burgdorferi antigens, including OspA, -B, and -C compared to control groups that either had received unpulsed dendritic cells or were not treated. Finally, mice in the early stage of B. burgdorferi infection were able to develop anti-OspA antibody following injection with B. burgdorferi-pulsed dendritic cells. Our results demonstrate for the first time that adoptive transfer of B. burgdorferi-pulsed dendritic cells induces a protective immune response against tick-transmitted B. burgdorferi and stimulates the production of antibodies specific for a limited set of B. burgdorferi antigens in vivo.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9234802      PMCID: PMC175479          DOI: 10.1128/iai.65.8.3386-3390.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  38 in total

1.  TNF alpha interrupts antigen-presenting function of Langerhans cells by two mechanisms: loss of immunogenic peptides and impairment of antigen-independent T cell clustering.

Authors:  F Koch; E Kämpgen; B Trockenbacher; G Schuler; N Romani
Journal:  Adv Exp Med Biol       Date:  1995       Impact factor: 2.622

2.  Recombinant IL-4 treatment augments resistance to Borrelia burgdorferi infections in both normal susceptible and antibody-deficient susceptible mice.

Authors:  A Keane-Myers; C R Maliszewski; F D Finkelman; S P Nickell
Journal:  J Immunol       Date:  1996-04-01       Impact factor: 5.422

3.  Outer surface protein C (OspC), but not P39, is a protective immunogen against a tick-transmitted Borrelia burgdorferi challenge: evidence for a conformational protective epitope in OspC.

Authors:  R D Gilmore; K J Kappel; M C Dolan; T R Burkot; B J Johnson
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

4.  Human dendritic cells phagocytose and process Borrelia burgdorferi.

Authors:  L Filgueira; F O Nestlé; M Rittig; H I Joller; P Groscurth
Journal:  J Immunol       Date:  1996-10-01       Impact factor: 5.422

5.  Infiltration of CD4+ CD8+ T cells, and expression of ICAM-1, Ia antigens, IL-1 alpha and TNF-alpha in the skin lesion of BALB/c mice undergoing repeated infestations with nymphal Ixodes ricinus ticks.

Authors:  M L Mbow; B Rutti; M Brossard
Journal:  Immunology       Date:  1994-08       Impact factor: 7.397

6.  Bone marrow-derived macrophage lines and immortalized cloned macrophage and dendritic cells support priming of Borrelia burgdorferi--specific T cell responses in vitro and/or in vivo.

Authors:  U Altenschmidt; P Ricciardi-Castagnoli; M Modolell; H Otto; K H Wiesmüller; G Jung; M M Simon
Journal:  Immunol Lett       Date:  1996-04       Impact factor: 3.685

7.  Protective resistance to experimental Borrelia burgdorferi infection of mice by adoptive transfer of a CD4+ T cell clone.

Authors:  T D Rao; A B Frey
Journal:  Cell Immunol       Date:  1995-05       Impact factor: 4.868

8.  Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine.

Authors:  A M de Silva; S R Telford; L R Brunet; S W Barthold; E Fikrig
Journal:  J Exp Med       Date:  1996-01-01       Impact factor: 14.307

9.  Saliva of the Lyme disease vector, Ixodes dammini, blocks cell activation by a nonprostaglandin E2-dependent mechanism.

Authors:  S Urioste; L R Hall; S R Telford; R G Titus
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

10.  Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.

Authors:  F Sallusto; A Lanzavecchia
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

View more
  19 in total

Review 1.  Molecular events of bacterial-induced maturation of dendritic cells.

Authors:  M Rescigno; F Granucci; P Ricciardi-Castagnoli
Journal:  J Clin Immunol       Date:  2000-05       Impact factor: 8.317

2.  Vaccination with Bordetella pertussis-pulsed autologous or heterologous dendritic cells induces a mucosal antibody response in vivo and protects against infection.

Authors:  A George-Chandy; N Mielcarek; I Nordström; J Holmgren; K Eriksson
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

3.  Dendritic cells efficiently induce protective antiviral immunity.

Authors:  B Ludewig; S Ehl; U Karrer; B Odermatt; H Hengartner; R M Zinkernagel
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

4.  Fate of Mycobacterium tuberculosis within murine dendritic cells.

Authors:  K A Bodnar; N V Serbina; J L Flynn
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

5.  Analysis of mouse dendritic cell migration in vivo upon subcutaneous and intravenous injection.

Authors:  M B Lappin; J M Weiss; V Delattre; B Mai; H Dittmar; C Maier; K Manke; S Grabbe; S Martin; J C Simon
Journal:  Immunology       Date:  1999-10       Impact factor: 7.397

6.  Protection against pulmonary infection with Pseudomonas aeruginosa following immunization with P. aeruginosa-pulsed dendritic cells.

Authors:  S Worgall; T Kikuchi; R Singh; K Martushova; L Lande; R G Crystal
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

7.  Dendritic cell activation and cytokine production induced by group B Neisseria meningitidis: interleukin-12 production depends on lipopolysaccharide expression in intact bacteria.

Authors:  G L Dixon; P J Newton; B M Chain; D Katz; S R Andersen; S Wong; P van der Ley; N Klein; R E Callard
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

8.  Innate immune responses in Lyme borreliosis: enhanced tumour necrosis factor-alpha and interleukin-12 in asymptomatic individuals in response to live spirochetes.

Authors:  J Sjöwall; A Carlsson; O Vaarala; S Bergström; J Ernerudh; P Forsberg; C Ekerfelt
Journal:  Clin Exp Immunol       Date:  2005-07       Impact factor: 4.330

9.  Major histocompatibility complex class II-independent generation of neutralizing antibodies against T-cell-dependent Borrelia burgdorferi antigens presented by dendritic cells: regulation by NK and gammadelta T cells.

Authors:  M L Mbow; N Zeidner; R D Gilmore; M Dolan; J Piesman; R G Titus
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

10.  Effective induction of acquired resistance to Listeria monocytogenes by immunizing mice with in vivo-infected dendritic cells.

Authors:  Hiroshi Sashinami; Akio Nakane; Yoichiro Iwakura; Mutsuo Sasaki
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.